Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sciotec Diagnostic Technologies is a leading Austrian diagnostics company specializing in the development and commercialization of diagnostic kits and nutritional supplements targeting food intolerances, especially histamine intolerance. Its flagship products include the DAO enzyme-based DAOSiN supplement and the DAO‑REA diagnostic kit. The company has also conducted research on recombinant antibody fragments for neutralizing prolamins in celiac disease but these are not yet commercialized therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sciotec Diagnostic Technologies.